Prenatal diagnosis and treatment for fetal angiotensin converting enzyme deficiency
Prenatal Diagnosis · 2024
DOI: 10.1002/pd.6443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Hang-Jing Tan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Peptidyl-Dipeptidase A, Oligohydramnios. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
To elucidate an etiology in a case with persistent oligohydramnios by prenatal diagnosis and actively treat the case to achieve good prognosis.
Methods
We performed whole exome sequencing (WES) of DNA from the fetus and parents. Serial amnioinfusions were conducted until birth. Pressors were required to maintain normal blood pressure. The infant angiotensin‐converting enzyme (ACE) activity, angiotensin II (Ang II, a downstream product of ACE), and compensatory enzymes (CEs) activities were measured. Compensatory enzyme activities in plasma from age‐matched healthy controls were also detected.
Results
We identified a fetus with a severe ACE mutation prenatally. The infant was born prematurely without pulmonary dysplasia. Hypotension and anuria resolved spontaneously. He had almost no ACE activity, but his Ang II level and CE activity exceeded the upper limit of the normal range and the upper limit of the 95% confidence interval of controls, respectively. His renal function also largely recovered.
Conclusion
Fetuses with ACE mutations can be diagnosed prenatally through WES. Serial amnioinfusion permits the continuation of pregnancy in fetal ACE deficiency. Compensatory enzymes for defective ACE appeared postnatally. Renal function may be spared by preterm delivery; furthermore, for postnatal vasopressor therapy to begin, improving renal perfusion pressure before nephrogenesis has been completed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Reproduction and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
- Centers of System Biology, Data Information and Reproductive Health, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
- Department of Gynaecology and Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Reproductive Medicine Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Hong-Mei Xiao
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Key Research and Development Program of China
Zitieren
APA
Tan, H. J., Jian, W. Y., Lv, C., Guo, D. W., Liao, Z. C., Xu, H., Xiao, Y., Schiller, M., Zhuo, J. L., Yue, S. J., Yao, R. J., Deng, H. W., & Xiao, H. M. (2024). Prenatal diagnosis and treatment for fetal angiotensin converting enzyme deficiency. Prenatal Diagnosis. https://doi.org/10.1002/pd.6443
Vancouver
Tan HJ, Jian WY, Lv C, Guo DW, Liao ZC, Xu H, et al. Prenatal diagnosis and treatment for fetal angiotensin converting enzyme deficiency. Prenatal Diagnosis. 2024. doi:10.1002/pd.6443
BibTeX
@article{Tan2024,
author = {Tan, Hang-Jing and Jian, Wen-Yan and Lv, Chao and Guo, De-Wei and Liao, Zheng-Chang and Xu, Hui and Xiao, Yao and Schiller, Martin and Zhuo, Jia-Long and Yue, Shao-Jie and Yao, Ruo-Jin and Deng, Hong-Wen and Xiao, Hong-Mei},
title = {Prenatal diagnosis and treatment for fetal angiotensin converting enzyme deficiency},
journal = {Prenatal Diagnosis},
year = {2024},
doi = {10.1002/pd.6443}
}
EUVIMED